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ABSTRACT
Synthetic oligoribonucleotides have been used to
probe the interaction of MS2 coat protein with the
translational operator of the MS2 replicase gene. We
have investigated the possible formation of a transient
covalent bond between the single-stranded uridine
residue, at position - 5, and a cysteine side-chain on
the coat protein, by the incorporation of a chemically
modified residue (5-BrU) at this position. This
chemically synthesised operator variant has a binding
constant of between 10 and 50 times greater than that
of the wild type and is therefore comparable with the
tight binding variant having a cytidine substituted at the
- 5 position. Dissociation kinetics show that the
complex with the 5-BrU operator is more stable than
the - 5C variant; a result which is consistent with the
formation of a Michael adduct at the -5 position. In
addition, a number of other chemical variants of the
operator have been analysed. These include operators
incorporating deoxyadenine residues at each of the
important single-stranded adenine sites.
Recently the Michael adduct proposal has been
challenged on the basis of mutagenesis of the coat
protein cysteine residues (1). These results are
discussed in the light of our data in support of Michael
adduct formation.
INTRODUCTION
Many important cellular events are mediated by the specific
interaction of proteins with RNAs. However, despite the
importance of this class of interaction we still know very little
about the structural details of sequence-specific recognition of
RNAs by proteins. Structural studies of RNA-protein complexes
have been hampered by 1) the size or complexity of the RNA
components, 2) the relative instability of RNAs, and 3) by the
unavailability of large quantities of homogeneous complexes. A
considerable advance in this field would come from the ready
availability of synthetic RNAs and this has led to the development
of various RNA transcription systems for the production ofRNAs
in quantities sufficient for biochemical experiments (2,3,4).
However, these systems suffer several disadvantages,
which include the requirement for specific leader sequences for
efficient transcription to occur and the restriction to syntheses
containing naturally occuring nucleotides. In addition large scale
preparations are expensive and the products tend to contain
sufficient levels of mis-incorporation as to make structural studies
difficult (eg. by broadening NMR line widths).
Clearly an ideal solution would be the direct chemical synthesis
of oligoribonucleotides, which would have the potential for the
incorporation of novel chemical groupings and cost effective
production of material on a large scale. Several routes towards
chemical synthesis have been developed. Recently Ogilvie and
his colleagues have reported a method for the rapid and efficient
construction of ribo-oligonucleotides using automated solid phase
methods based on the phosphoramidite chemistry (5) which has
proved very successful for the synthesis ofDNA oligonucleotides.
Since many biochemical laboratories have access to solid-phase
oligonucleotide synthesisers this development should allow
chemically synthesised oligoribonucleotides to be used in place
of in vitro transcripts for both functional and structural studies.
We have utilised the Ogilvie method to produce synthetic
oligoribonucleotides to study RNA-protein interactions in the
MS2(R17) translational repression complex. Uhlenbeck and his
colleagues have shown that the coat protein recognition site
(translational operator) is limited to a 19 base stem-loop (Fig. 1).
By the use of sequence variants produced enzymatically it has
been shown that essentially all the sequence can be varied without
affecting binding. The only requirements appear to be for the
secondary structure to be preserved ie. the base-paired stem, and
for positions -10 to be a purine, -5 to be a pyrimidine, with
adenines at -7 and -4 (6-9).
The pyrimidine requirement at -5 has been explained by the
evidence in support of Michael addition to this residue by a
protein cysteine during complex formation (10). Changing the
-5U to a cytidine results in an RNA with a binding constant
approximately 50 times greater than that of the wild type sequence
(11). High concentrations of a variety of 5-halogenated
pyrimidines and some sulphydryl reagents inactivate coat protein
for RNA binding. The observation of similar nucleoside
inactivation in thymidylate synthetase (12) and isoleucine tRNA
synthetase (13) has been interpreted as a consequence of the
formation of a transient covalent complex between the C-6 of
a pyrimidine and a protein cysteine. The tighter binding of the
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Figure 1 (a) Proposed secondary structure of the stem loop fragment of MS2 RNA which contains all the information necessary to bind coat grotein specifically
(9). The numbers arrowed on the left hand figure indicate the values of K. determined for the sequence changes indicated. Wild type K. 1x 10 M. The sequence,
in this figure and throughout the text is numbered relative to the first nucleotide of the replicase gene (+ 1). (b) Shows the minimum sequence information required
for specific binding.
MS2 C-variant is consistent with the fact that the Michael adduct
with cytidine is more stable than with uridine (11).
We have been studying the MS2 translational operator complex
in order to understand the basis of sequence-specific recognition
and binding by the coat protein. To this end we have produced
a library of single, double or triple random coding mutations
throughout the coat protein gene. The mutant proteins are being
analysed for their stability, ability to self-assemble and RNA-
binding properties. The determination of the three-dimensional
structure of the MS2 capsid by X-ray diffraction techniques
should eventually allow all these mutations to be understood in
terms of a molecular model of the coat protein. We have also
developed a modelling algorithm for RNA stem loop structures
(14), which has allowed us to produce a three-dimensional model
of the operator fragment. Chemical and enzymatic probes have
been used to test key features of the model (in vitro) and suggest
that it is a good approximation of the structure in solution. The
model also explains many of the results of sequence variation
experiments in terms of the requirement to maintain the overall
operator structure rather than the loss of specific functional
groups. The use of synthetic oligoribonucleotides in this system
has the advantage that there are excellent in vitro assays for the
biological function of the RNA fragments (7) and the wealth of
knowledge about sequence recognition can be used to direct the
synthesis of operators bearing novel functional groups.
MATERIALS AND METHODS
Chemical synthesis of oligoribonucleotides
Chemical synthesis of oligoribonucleotides was performed as
described by Ogilvie et al(5). All syntheses were performed on
a 0.2,gM scale. Cyanoethyl esters rather than 0-Methyl esters
were used for the 5-BrU synthesis in order to avoid the use of
Table 1. List of oligoribonucleotides synthesised and the details of eachsynthesis.
Yields are based on trityl assays. All syntheses were carried out on a 0.2 itmole
scale.
Oligonucleotide Overall Average Lowest Highest Total
Ifeld(%) Step Yield Step Step (4tg)
1 MS2 wt 40.6 94.8 84.9 100 730
2 MS2 varl (20mer) 28.5 93.3 83.1 100 473
3 MS2 var2 (-10dA) 34.6 94.0 77.4 100 660
4 MS2 var3 (-7dA) 36.7 94.3 76.5 100 560
5 MS2 var4 (-4dA) 39.2 94.6 80.0 100 700
6 MS2 var5 (-5 5-BrU)31.8 93.5 70.9 100 560
thiophenol. The DMT-ribonucleotide-phosphoramidites were
purchased from Peninsula Laboratories Europe Ltd..
Initial purification of the crude oligoribonucleotides was
performed by reverse phase HPLC on a C18 column (Beckman
Ultrasphere 5tm,4.6x280 mm). The RNA was loaded onto the
column after the final deprotection and desalting step and was
eluted with a linear gradient of 7- 13% acetonitrile buffered at
pH 7.5 with 100mM ammonium acetate. Fractions containing
the semi-purified fulll-length oligoribonucleotide were pooled and
then lyophilised.
The synthetic RNA was then labelled either at the 3' terminus
with 5'[32P]pCp and RNA ligase (BRL) (15), or at the 5'
terminus with 'y[32P]ATP and T4 polynucleotide kinase
(Pharmacia) (16), and purified on 1.5mm thick 20% (w/v)
polyacrylamide gels containing 7M urea, 0.1M Tris-Borate
pH8.1, 2mM EDTA (17).
Synthesis and protection of 5-bromouridine
5-BrU was synthesised as described by Levene etal (18), 5' and
2' protection was as described by Hakimelahi et al (19), and 3'
protection as described by Ogilvie et al (S).
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Figure 2 Enzymatic sequencing of synthetic oligoribonucleotides. Gel purified
RNAs radiolabelled at either the 5' or 3' ends were sequenced using the sequence
specific nuclease technique (21). Panel A: MS2 wt, Panel B: -5 (5-Br) uridine
variant and Panel C: -10 deoxy A variant. Arrows indicate positions of absent
or aberrant bands due to the presence of the modified nucleotides.
Base compositional analysis
As described by Eadie et al (20).
Binding assays
Filter binding affinity and dissociation assays were performed
as described by Carey and Uhlenbeck (7).
Gel retardation
Complexes were formed between 10pM RNA (5' labelled) and
varying concentrations of coat protein in 251d 50mM Tris-acetate
pH 7.6, 1mM magnesium acetate, 10% (w/v) ficoll, 0.05% (w/v)
xylene cyanol and bromophenol blue, for 3hrs at 2°C. The
samples were then run on 10% (w/v) acrylamide gels containing
5OmM Tris-acetate pH 7.6, 1mM magnesium acetate for 3hrs
at 4°C with re-circulation of the running buffer. Gels were pre-
run for 30min prior to loading of the samples. All gels were dried
under vacuum before autoradiography.
Figure 3 Base composition analysis of synthetic oligoribonucleotides. HPLC
profiles of a) ribonucleoside standards and b) variant 5 (-5, 5-BrU) digested
and processed as described in Materials and Methods. Nucleosides were
fractionated on a C18 reverse phase column (250x2.5 mm) with a gradient of
0 to 90% methanol in 50mM Na2HPO4 pH5.5. Gradient profile (dotted line)
was 0% B, 10 min: to 15% B, 30 min: 15% B for 10 min: to 45% B over 30
min: then to 100% B over 30 min. Profiles are absorbance traces at 254nm. Peak
fractions were pooled, lyophilised and analysed by thin layer chromatography
alongside standards. The doubling of the peaks in trace B was due to a problem
with the C18 column, TLC of both sections of each peak showed that they
contained identical material.
RESULTS AND DISCUSSION
Chemical synthesis of oligoribonucleotides
All RNAs used in this study were synthesised chemically using
the methods described by Ogilvie et al (5), with the modifications
described in Materials and Methods (Table 1). Initially the final
desalting step after treatment with TBAF in THF was also omitted
and instead, the crude deprotected RNA was applied directly onto
a C18 reverse phase HPLC column and eluted with a linear
gradient of 7-13% acetonitrile buffered at pH 7.5 with 0. IM
ammonium acetate. However, this led to aggregation problems
between the RNA fragment and the column matrix due to the
presence of tetrabutyl ammonium ions. To prevent this the
deprotected material was passed through Dowex 50 (NH4+
form) before application to the C18 column. This was much faster
than desalting by gel filtration on Sephadex G-10. The HPLC
step had the benefit of partially purifying the full length RNA
from failure sequences and non-deprotected RNA, prior to end-
labelling and final purification by gel electrophoresis (17).
A
t5' 4
A
C
A
U
G
A -10
G
G
A -7
U
U
3524 Nucleic Acids Research, Vol. 18, No. 12
-m -8 -7
L0ge, Cost Protein CM)
b
80
70-
s0-
50-
lo
c
3 40-
a
0
U
* 30-
It
20
10-
-_ -8
-7
Lo0O Coat Protein CMJ
a
0
U
It
0 C-loop
* WIld type
-10A deletion
-5
* 5-BrmU
-1OdA
O -7dA
*
-4dA
-s
-5
o 1
Nucleic Acids Research, Vol. 18, No. 12 3525
* 2aC
O io0c
* 21 °C
o 370C
-e
-5
Logio Coat Protein CM)
Figure 4 (a) Coat protein excess binding curves for sequence variants of the MS2 operator. Filter binding assays were performed as described (7). (b) Affinity
curves of the synthetic operators containing variant nucleotide or sugar residues. (c) The effect of temperature on the affinity of coat protein for the 5-BrU variant.
The average step-wise yields as determined by trityl release
were 90-98% giving overall yields from 20-48% (Table One).
There was considerable variability between different batches of
phosphoramidites. The guanosine reagent was particularly
troublesome. Solutions of this compound often precipitated on
standing but after subsequent filtration gave high coupling
efficiencies. Similar problems were encountered in the initial
commercial supplies of the deoxy series of phosphoramidites and
have been shown to be due to excess phosphitylating reagent (A.
Andrus, personal communication). Synthesiser set-up chemicals
from different suppliers also gave variable yields. The best results
to date have been obtained with chemicals from Applied
Biosystems. The results with the 5-bromouridine compound
demonstrated the potential of this chemistry for utilising non-
standard nucleotide groupings. The step yields for this compound
were noticeably lower than those for the commercial reagents.
This was probably due to the impurity of the brominated
compound, since subsequent repurification resulted in higher
coupling efficiencies. This compound is unstable and decays with
time. Our results suggest that phosphoramidite purity is the major
factor in coupling yields. The results with the deoxyadenosine
derivatives suggest that all the chemical variants already available
in the deoxy series could be incorporated into RNA fragments
by this method.
Sequence and base composition analysis
All RNAs were sequenced enzymatically (21), and terminal
nucleotides confirmed by P1 (5' terminus) and T2 (3' terminus)
digestions followed by thin layer chromatography. Fig. 2 shows
Table 2. Thermodynamic and kinetic properties of coat protein binding to wild
type and variant operator fragments.
Operator kass kdiss_I t%
M- nun miun-
Wild type l07 0.15 0.70
-5 C variant 6x107 1.7x10-3 408
-lOdA 107 -
-7dA 107 -
-4dA 107 -
-5-5BrU 2 x108 &2x 107 1.6 x 10-3 433
- IOA deletion no detectible affinity
enzymatic sequencing gels of the oligoribonucleotides used. All
the synthetic fragments are correctly recognised at the positions
of the naturally occuring bases. The 5-BrU residue is cleaved
only by the B. cereus enzyme (normally specific for C & U)
and the deoxyadenine positions are not cleaved. In addition to
sequence analysis, the oligoribonucleotides were digested to
completion with snake venom phosphodiesterase and alkaline
phosphatase, and the resulting nucleoside mixture separated by
reverse phase chromatography. The nucleosides were eluted with
a gradient of 0-90% methanol buffered at pH 7.0 with 50mM
phosphate buffer. Fig. 3 shows a representative HPLC trace of
such a base composition analysis forthe 5-BrU containing
oligoribonucleotide.
Each peak was assigned by comparison with elution times of
nucleoside standards, and by direct comparison on thin layer
chromatography plates (data not shown).
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dissociation of the complex with the 5 BrU derivative reveals
a dramatic increase in the half-life as predicted as a consequence
of Michael adduct formation with a nucleotide containing the
electron withdrawing substituent at the 5 position.
The kinetics of operator-coat protein dissociation were reflected
c 40 RNA/P!. by the behaviour of the complexes in polyacrylamide gels (Fig.
5). The C-variant complex is sufficiently stable that it can be
identified as a distinct retarded band. The 5 BrU derivative
produced a similar retarded species, which co-electrophoresed
with the C-variant complex. No other species were detected in
the gel which might have accounted for the high and low affinity
interactions between this RNA variant and the coat protein.
CONCLUSIONS
Figure 5 Analysis of complexes between coat protein and A) C-loop; B) 5-BrU
19 mer RNA by polyacrylamide gel electrophoresis. Coat protein concentrations
are lane 1; zero, 2; lnM, 3; lOnM, 4; lOOnM, 5; ljM, 6; 1O%M . RNA
concentrations were kept constant at 10pM. The faster moving band on the
autoradiogram corresponds to firee 19 mer and the slower one to the RNA-protein
complex.
Kinetic and Thennodynamic Analysis
Carey and Uhlenbeck (7) have established a filter binding assay
to study the interaction of coat protein with operator fragments.
Analysis of a synthetic wild-type sequence, the -SC variant, and
the -10 variant (Table 1), by these methods, showed that the
synthetic oligoribonucleotides were recognised normally by coat
protein. That is the half-maximal binding and saturation of both
the wild-type and tight-binding -SC variant affmity curves were
approximately equal to that seen for operator fragments derived
from the phage (6) or from in vitro transcription assays (9) and
is a reflection of the intrinsic RNA-protein affinity and the
retention efficiency of the filter (Fig. 4a). The -10 variant did
not bind coat protein at concentrations where binding is specific.
Substitution of adenines at -4, -7 and -10 by dA resulted in
small decreases in the affinity for coat protein suggesting that
the operator structure is not greatly disturbed by these changes
(Fig. 4b) and that there are no direct contacts made between the
protein and the 2' hydroxyl group.
The 5 BrU derivative shows a complex affinity curve with an
apparent initial saturation of some 20% of the input RNA with
a half-maximal concentration of coat protein of 10-8M followed
by a second increase in binding with an apparent affinity slightly
lower than wild-type but with an identical saturation. Affinity
measurements at different temperatures (Fig. 4c) showed that as
the temperature is increased the complex behaviour disappears
to produce an apparently single binding curve. As with the wild-
type sequence the apparent affinity decreases with increasing
temperature. At temperatures below 21°C there appears to be
two classes of operator fragment as judged by their affinity for
coat protein. The amount of the high affinity component is
apparentdy reduced by increasing temperature.
The kinetics of the interaction between coat protein and the
RNA variants have been assessed by determination of the rates
of dissociation of the complexes (Table Two). The rate of
Several approaches toward chemical synthesis of ribo-
oligonucleotides have been reported in the literature (5, 22, 23,
24, 25). However, most of these have been restricted by their
complexity to synthetic organic chemistry laboratories and are
not readily available to biochemists. The approach of Ogilvie (5)
has the advantage that the synthesis uses phosphoramidite
chemistry similar to that used for the solid phase synthesis of
DNA oligonucleotides. This allows ribo-oligonucleotides to be
synthesised automatically using existing solid-phase DNA
synthesizers which are widely available.
Various problems occur with the synthesis and deprotection
of ribo-oligonucleotides which are not relevant to the deoxy
series. The most important of these is interconversion of
phosphate esters between the 2' and 3' positions. The use of 2'
silyl protected nucleotides, which are subsequently deprotected
in the presence of fluoride ions appears to have overcome this
problem (5). It is, however, important to test the synthetic
products of this methodology extensively before its use becomes
routine. The synthesis of a tRNA(70mer) which is correctly
charged with its cognate amino acid has been reported (26),
together with the large scale ( 20%mole) synthesis and purification
of a self-complementary 12mer (23). This duplex has been
subjected to high-resolution 2D 'H NMR which failed to detect
significant chemical inhomogeneity.
Here we report the use of this synthesis technology to probe
the details of a well-characterised RNA-protein recognition event
in the formation of the MS2 translational repression complex.
This complex has the advantage that it has been extensively
studied in terms of sequence specificity (9) and allows detailed
comparisons to be made with the synthetic products.
Our results of filter-binding with sequence variants suggested
that the synthetic ribo-oligonucleotides are correctly recognised
by the MS2 coat protein with KY's identical, within experimental
error, to those obtained with the operator RNA transcribed in
vitro. Furthermore, saturation values for coat protein binding
indicate that the bulk of the material is competent for binding.
The synthetic ribo-oligonucleotides are also correctly recognised
by the sequence-specific RNases used to confirm their sequences.
These reactions appear highly specific since fragments containing
chemically variant groups (5 BrU or deoxy adenine) are mis-
recognised or resistant to cleavage.
The versatility of this approach for analysing RNA-protein
interactions has been demonstrated by the incorporation of
chemically modified groups. The filter binding data with the 5
BrU derivative strongly suggest that a Michael adduct forms
between the coat protein and the operator fragment. This
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Figure 6 (a) Proposed mechanism for formation of Michael adduct between protein cysteine and the -5 pyrimidine. In the light of results from protein mutagenesis
experiments (1), the Michael donor need not necessarily be cysteine. (b) Framework representation of the structure of the MS2 operator fragment deduced from
molecular modelling and structure probing experiments (14). The position of the C6 atom in the model structure is indicated. Below is a diagram of the possible
diastereomers which may form with the 5-bromouridine derivative.Formation of the cis diastereomers might be expected to be irreversible.
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suggestion has recently been challenged by Peabody (1) on the
basis of coat protein mutagenesis experiments. He reports that
in vivo binding to the operator fragment still occurs when both
coat protein cysteine residues (positions 46 and 101) are mutated
to groups incapable of Michael addition. (Chemical
modification/inactivation experiments strongly implicated a
cysteine residue as the potential Michael donor (27)). Our results
are consistent with the formation of such a Michael adduct at
the -5 position, but do not yield any information about the
Michael donor. The absence of adduct formation may not
completely abolish coat protein binding since Uhlenbeck has
shown that substitution of either purine at position -5 results
in a fragment with ten to twenty fold lower affinity, which might
be overcome at high protein concentrations. We have constructed
mutants at both Cys46 and Cys'0l and are currently examining
their interaction with both wild-type and 5 BrU substituted
operator fragments (Macedo and Stockley, in progress).
The behaviour of the 5 BrU derivative in the filter-binding assay
apparently reveals the presence of two-components in the reaction
mixture. This effect is temperature-dependent, and quite
reproducible. Several possibilities which might account for this
result have been considered. These are i) bromine substitution
leading to a tautomeric shift of the base at the -5 position, ii)
differential exposure of the target C6 atom due to hindered
rotation of the substituted base around Cl', iii) preferential
interaction by the coat protein with one of the two possible
diastereomers which could be formed during Michael addition
(Fig.6) and iv) two differing conformations of the coat protein
ligand. We exclude, i) because the NMR spectrum of the
protected 5-bromouridine phosphoramidite is consistent with the
presence of only the keto form, and iv) because if the effect were
due to the presence of several protein conformations it should
have been observable with the otherRNA fragments. A molecular
model of the operator fragment has been built which suggests
that the C6 atom is not accessible from the solvent (14) consistent
with ii). In order to discriminate between the hindered rotamer
and the diastereomer effects we are synthesizing other Michael
acceptors, e.g. 5-CN.U, which retain the electron withdrawal
properties of Br but are much smaller (Goodman et al, in
progress).
The results with the deoxyadenosine substitutions show the
advantage of compatible chemistry between the deoxy and the
ribo phosphoramidite series. In particular for RNA's, it should
be possible to examine the role of the 2' hydroxyl group by
synthesizing mixed ribo-deoxy oligonucleotides. This might be
especially useful in examining RNA's in which the 2' hydroxyl
group is suspected of an important structural or functional role
(such as formation of a H-bond with a protein or other ligand,
or direct participation in a chemical reaction). Deoxy substitution
at all three important adenine positions in the MS2 translational
operator suggests little or no effect on this recognition event.
These data confirm the usefulness of the Ogilvie approach to
chemical synthesis of ribo-oligonucleotides and highlight the
potential for its application to a wide number of exciting problems
involving RNA.
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